BioLine Rx Stock (NASDAQ: BLRX) stock price, news, charts, stock research, profile.
You can purchase shares of BioLine Rx (NASDAQ:BLRX) through any online brokerage.
Other companies in BioLine Rx’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Acurx Pharmaceuticals (NASDAQ:ACXP), CARISMA Therapeutics (NASDAQ:CARM), Imunon (NASDAQ:IMNN) and Bolt Biotherapeutics (NASDAQ:BOLT).
BioLine Rx has a consensus price target of $5.00.
The stock price for BioLine Rx (NASDAQ: BLRX) is $0.2084 last updated December 20, 2024 at 6:31 PM EST.
There are no upcoming dividends for BioLine Rx.
BioLine Rx’s Q3 earnings are confirmed for Monday, November 25, 2024.
There is no upcoming split for BioLine Rx.
BioLine Rx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.